Mark Levick
Director/Miembro de la Junta en InterAx Biotech AG .
Perfil
Mark Levick is currently the Director at InterAx Biotech AG since 2023.
Prior to this, he was the Chief Executive Officer at Alvotech hf and Alvotech from 2019 to 2023.
He also served as the Global Head at Novartis AG and Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick holds a doctorate degree from the University of Cambridge and an undergraduate degree from The University of Newcastle.
Cargos activos de Mark Levick
| Empresas | Cargo | Inicio |
|---|---|---|
InterAx Biotech AG
 InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Director/Miembro de la Junta | 03/10/2023 |
Antiguos cargos conocidos de Mark Levick.
| Empresas | Cargo | Fin |
|---|---|---|
| ALVOTECH | Director Ejecutivo | 01/01/2023 |
| Sandoz Biopharmaceuticals | Corporate Officer/Principal | 01/01/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/07/2016 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Director Ejecutivo | - |
Formación de Mark Levick.
| University of Cambridge | Doctorate Degree |
| The University of Newcastle | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| ALVOTECH | Health Technology |
| Empresas privadas | 3 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Commercial Services |
| Sandoz Biopharmaceuticals |
- Bolsa de valores
- Insiders
- Mark Levick
